The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Guiffre Christopherd T since 2006.
This trader's CIK number is 1219021.
At the time of last reporting, Guiffre Christopherd T was the CFO, COO, Treas., & Asst. Sec. of Pear Therapeutics, Inc.. (stock ticker symbol PEAR).
Also see all insider trading activities at Pear Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | PEAR | 0 | $0 | 0 | $0 | 49,500 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | CBST | 0 | $0 | 46,317 | $1,000,940 | 45,000 | $448,050 |
2006 | CBST | 0 | $0 | 5,625 | $125,707 | 5,625 | $42,637 |
1. Pear Therapeutics, Inc. (PEAR)
2. Cubist Pharmaceuticals Inc (CBST)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-01-14 | PEAR | Option Ex | 49,500 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-07-25 | CBST | Option Ex | 20,000 | 10.84 | 216,800 |
2007-07-25 | CBST | Sale | 20,226 | 22.86 | 462,427 |
2007-05-30 | CBST | Option Ex | 15,000 | 9.25 | 138,750 |
2007-05-30 | CBST | Sale | 15,000 | 22.57 | 338,565 |
2007-01-31 | CBST | Option Ex | 10,000 | 9.25 | 92,500 |
2007-01-31 | CBST | Sale | 11,091 | 18.03 | 199,948 |
2006-09-01 | CBST | Option Ex | 2,625 | 7.58 | 19,897 |
2006-09-01 | CBST | Sale | 2,625 | 23.42 | 61,477 |
2006-02-01 | CBST | Option Ex | 3,000 | 7.58 | 22,740 |
2006-02-01 | CBST | Sale | 3,000 | 21.41 | 64,230 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Guiffre Christopherd T (CFO, COO, Treas., & Asst. Sec. of Pear Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.